- Home
- Companies
- usa nevada
- protein expression
Show results for
Refine by
Protein Expression Suppliers Serving Nevada
148 companies found
based inGöttingen, GERMANY
IBA GmbH is a biotechnology company providing products for life science research in academia and industry. We develop high performance research tools for cell and protein isolation based on our proprietary Strep-tag technology. Situated in ...
based inIslandia, NEW YORK (USA)
Crescent Chemical Co., Inc. is a national distributor of Environmental and Analytical reference standards, Karl Fischer reagents and titrators, biochemicals, electrophoresis consumables and instruments, and fine organic and inorganic chemicals. ...
based inSouth San Francisco, CALIFORNIA (USA)
At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX1325 is designed ...
based inWest Vancouver, BRITISH COLUMBIA (CANADA)
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. ...
based inSan Jose, CALIFORNIA (USA)
Founded in 2005 and headquartered in San Jose, California, Advansta accelerates life science research by developing and supplying novel protein characterization tools that offer superior performance, simplicity, and convenience. Advansta’s mission ...
In December of 2019, the SARS-CoV-2 virus, which causes the disease COVID-19, was first detected in Wuhan, China. The SARS-CoV-2 virus is a single-stranded RNA coronavirus that causes respiratory infections. The rapid spread of COVID-19 has resulted ...
based inLaramie, WYOMING (USA)
GlycoBac has developed a sensitive assay for infectious Sf-rhabdovirus particles using our proprietary Sf-RVN cell line. GlycoBac has partnered with MilliporeSigma to facilitate the distribution of our Sf-RVN cell line for commercial vaccine and ...
Sf-RVN is an Sf-rhabdovirus-free S. frugiperda cell line that can seamlessly replace the widely used, but persistently virally contaminated Sf9 or Sf21 cell lines for recombinant protein or rAAV production. ...
based inParis, FRANCE
Ariana Pharma is a leading Al driven Precision Medicine Company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems. Using its KEM Explainable Artificial Intelligence (XAl) technology, Ariana ...
Ariana Pharma has developed KEM® (Knowledge Extraction and Management) the most advanced Explainable Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to ...
based inFremont, CALIFORNIA (USA)
Ultima Genomics is a pioneering company in the genomics sector, focusing on revolutionizing genomic sequencing through innovative technology and new sequencing architecture. The company's mission is to expand the scale of omics information, thereby ...
based inShirley, NEW YORK (USA)
Creative Biostructure is specialized in providing cost-effective contract services to both academia and biotech/pharmaceutical industries in the field of structural biology and membrane protein technologies. We have developed an all-in-one, ...
The formation of virus-like particles (VLPs) is a result of self-assembly of one or several types of viral structural proteins, such as Envelope or Capsid. The component proteins can originate from different viruses ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
Following breast cancer surgery, a HER2/neu 3+ patient receives trastuzumab (Genentech/Roche’s Herceptin, a monoclonal antibody treatment that targets the HER2/neu protein) in the first year and then hopes that their breast ...
based inAbingdon, UNITED KINGDOM
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, ...
based inLachen, SWITZERLAND
We are the largest privately owned and independent plasma fractionator in the world. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 ...
based inMadison, WISCONSIN (USA)
Scarab Genomics LLC was founded in 2002 by Professor F. Blattner, a serial entrepreneur and founder of DNASTAR Inc. and Nimblegen Inc. and a world-renowned scientist and leader in the genomics revolution. The Company was established to commercialize ...
Clean Genome® E. coli has eliminated inherent troublesome and unnecessary genes to create a production host that generates recombinant proteins and nucleic acids efficiently and continuously without compromising the product or the ...
based inWest Allis, WISCONSIN (USA)
Protein Foundry supplies the biomedical research community with chemokines and other recombinant proteins that meet the highest standards of quality. Our manufacturing methods yield molecules of the highest purity with minimal variation between ...
Human CCL5, also known as Regulated upon Activation, Normal T cell Expressed and presumably Secreted (RANTES), attracts and activates leukocytes and plays a primary role in the inflammatory immune response. CCL5 activates several G ...
based inMünchen, GERMANY
NanoTemper Technologies is deeply committed to the best customer experience. Central to this is a strong focus on high quality products made in Germany that enable researchers to easily, efficiently, and accurately perform protein characterization. ...
Poor expression levels, solubilization, and stability are well-known challenges in the production of recombinant membrane proteins. Selecting the best expression conditions typically focuses only on ...
based inWokingham, UNITED KINGDOM
SGS M-Scan is a world leading group of chemical analysis laboratories specialized in chemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inSan Francisco, CALIFORNIA (USA)
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize ...
Finally, an incubator designed specifically for the cultivation of primary human cells. The AVATAR System lets you fine-tune oxygen and pressure levels to cater culture conditions to your cell type of interest. Customizing settings based on tumor ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid tumors, significant ...